These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 10671332

  • 1. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
    Nucci M, Biasoli I, Akiti T, Silveira F, Solza C, Barreiros G, Spector N, Derossi A, Pulcheri W.
    Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
    [Abstract] [Full Text] [Related]

  • 2. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany.
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [Abstract] [Full Text] [Related]

  • 3. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto.
    Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, Girmenia C, Barbabietola G, Pagańo L, Leoni P, Specchia G, Caiozzo A, Raimondi R, Mandelli F.
    Clin Infect Dis; 1999 Feb; 28(2):250-5. PubMed ID: 10064240
    [Abstract] [Full Text] [Related]

  • 4. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
    Harousseau JL, Dekker AW, Stamatoullas-Bastard A, Fassas A, Linkesch W, Gouveia J, De Bock R, Rovira M, Seifert WF, Joosen H, Peeters M, De Beule K.
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD, Ghent C, Grant D, Horbay GL, McDougal J, David Colby W.
    Transplantation; 2003 Sep 27; 76(6):977-83. PubMed ID: 14508365
    [Abstract] [Full Text] [Related]

  • 6. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC.
    Mycoses; 1999 Sep 27; 42 Suppl 2():121-4. PubMed ID: 10865918
    [Abstract] [Full Text] [Related]

  • 7. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution.
    Lass-Flörl C, Gunsilius E, Gastl G, Englisch M, Koch G, Ulmer H, Dierich MP, Petzer A.
    Ann Hematol; 2003 Sep 27; 82(9):565-9. PubMed ID: 14504812
    [Abstract] [Full Text] [Related]

  • 8. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
    Rijnders BJ, Cornelissen JJ, Slobbe L, Becker MJ, Doorduijn JK, Hop WC, Ruijgrok EJ, Löwenberg B, Vulto A, Lugtenburg PJ, de Marie S.
    Clin Infect Dis; 2008 May 01; 46(9):1401-8. PubMed ID: 18419443
    [Abstract] [Full Text] [Related]

  • 9. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R, Lopez R, Sureda A, Brunet S, Domingo-Albós A.
    Haematologica; 1997 May 01; 82(3):297-304. PubMed ID: 9234575
    [Abstract] [Full Text] [Related]

  • 10. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP, Kurup A, Goh YT, Fook-Chong SM, Tan PH.
    Am J Hematol; 2002 Dec 01; 71(4):260-7. PubMed ID: 12447954
    [Abstract] [Full Text] [Related]

  • 11. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J.
    Bone Marrow Transplant; 2001 Nov 01; 28(9):873-8. PubMed ID: 11781648
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH, Ritter J, Müller FM.
    Klin Padiatr; 2001 Sep 01; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [Abstract] [Full Text] [Related]

  • 13. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A, Prentice AG.
    J Antimicrob Chemother; 2005 Sep 01; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [Abstract] [Full Text] [Related]

  • 14. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dhédin N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S, Schwarzinger M.
    Clin Infect Dis; 2009 Apr 15; 48(8):1042-51. PubMed ID: 19281327
    [Abstract] [Full Text] [Related]

  • 15. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
    Tollemar J, Ringdén O, Andersson S, Sundberg B, Ljungman P, Tydén G.
    Bone Marrow Transplant; 1993 Dec 15; 12(6):577-82. PubMed ID: 8136741
    [Abstract] [Full Text] [Related]

  • 16. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul 15; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 17. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO, Bowman JL, Penzak SR.
    Pharmacotherapy; 1998 Jul 15; 18(3):549-64. PubMed ID: 9620106
    [Abstract] [Full Text] [Related]

  • 18. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A, Prentice A, Gorschlüter M, Engelhart S, Hahn C, Djulbegovic B, Schmidt-Wolf IG.
    J Clin Oncol; 2003 Dec 15; 21(24):4615-26. PubMed ID: 14673051
    [Abstract] [Full Text] [Related]

  • 19. [Prophylaxis against mycoses in neutropenic patients].
    Arning M, Aul C.
    Mycoses; 1994 Dec 15; 37 Suppl 2():70-6. PubMed ID: 7541892
    [Abstract] [Full Text] [Related]

  • 20. Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders.
    Foot AB, Veys PA, Gibson BE.
    Bone Marrow Transplant; 1999 Nov 15; 24(10):1089-93. PubMed ID: 10578159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.